Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Cancer Screening Center, National Cancer Center Hospital, Tokyo, Japan.
Dig Endosc. 2024 Nov;36(11):1245-1252. doi: 10.1111/den.14808. Epub 2024 May 22.
Endoscopic hand suturing (EHS) is a novel technique for closing a mucosal defect after endoscopic submucosal dissection (ESD). We investigated the technical feasibility of colorectal EHS using a modified flexible through-the-scope needle holder.
This was a prospective multicenter study conducted at two referral centers between June 2022 and April 2023. This study included colorectal neoplasms 20-50 mm in size located in the sigmoid colon or rectum. A modified flexible through-the-scope needle holder, with an increased jaw width to facilitate needle grasping, was used for colorectal EHS. The primary end-points were sustained closure rate on second-look endoscopy (SLE) performed on postoperative days 3-4 and suturing time for colorectal EHS. Secondary end-points included complete closure rate and delayed adverse events.
We enrolled 20 colorectal neoplasms in 20 patients, including four patients receiving antithrombotic agents. The tumor location was as follows: lower rectum (n = 8), upper rectum (n = 2), rectosigmoid colon (n = 4), and sigmoid colon (n = 6), and the median mucosal defect size was 37 mm (range, 21-65 mm). The complete closure rate was 90% (18/20 [95% confidence interval (CI) 68.3-98.8%]), and the median suturing time was 49 min (range, 23-92 min [95% CI 35-68 min]). Sustained closure rate on SLE was 85% (17/20 [95% CI 62.1-96.8%]). No delayed adverse events were observed.
EHS demonstrated a high sustained closure rate. Given the long suturing time and technical difficulty, EHS should be reserved for cases with a high risk of delayed adverse events.
内镜手缝术(EHS)是一种用于内镜黏膜下剥离(ESD)后闭合黏膜缺损的新技术。我们使用改良的灵活经内镜针持器研究了结直肠 EHS 的技术可行性。
这是一项于 2022 年 6 月至 2023 年 4 月在两个转诊中心进行的前瞻性多中心研究。该研究纳入了大小为 20-50mm 的结直肠肿瘤,位于乙状结肠或直肠。改良的灵活经内镜针持器,其钳口宽度增加以方便抓针,用于结直肠 EHS。主要终点是术后 3-4 天行第二次内镜检查(SLE)时的持续闭合率和结直肠 EHS 的缝合时间。次要终点包括完全闭合率和迟发性不良事件。
我们纳入了 20 名患者的 20 个结直肠肿瘤,其中 4 名患者正在接受抗血栓药物治疗。肿瘤位置如下:低位直肠(n=8)、高位直肠(n=2)、直肠乙状结肠(n=4)和乙状结肠(n=6),中位黏膜缺损大小为 37mm(范围 21-65mm)。完全闭合率为 90%(18/20 [95%置信区间 68.3-98.8%]),中位缝合时间为 49 分钟(范围 23-92 分钟[95%置信区间 35-68 分钟])。SLE 时的持续闭合率为 85%(17/20 [95%置信区间 62.1-96.8%])。未观察到迟发性不良事件。
EHS 显示出较高的持续闭合率。鉴于缝合时间长且技术难度大,EHS 应保留用于迟发性不良事件风险较高的病例。